Development of a Practical, Minimally Invasive Seizure Gauge

Sponsor
Mayo Clinic (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT03745118
Collaborator
(none)
80
1
1
45.4
1.8

Study Details

Study Description

Brief Summary

The researchers are trying to assess changes in physiological signals before and during seizures.

Condition or Disease Intervention/Treatment Phase
  • Device: EpiTel EpiLog
  • Device: Byte Flies Sensor Dots
  • Device: Empatica E4
  • Device: Biovotion Everion
  • Device: GeneActiv
N/A

Detailed Description

Subjects that are undergoing video EEG monitoring in the hospital for their epilepsy at Mayo Clinic will be consented to participate in this study for a minimum of two days and/or the duration of their hospital stay for their clinical care. Subjects will be asked to wear up to 4 different commercially available seizure detection devices and complete surveys.

In the second year of the study patients who have implanted devices capable of recording or detecting seizures will be recruited to wear a noninvasive biosensor for multiple months. This data will be used to develop algorithms capable of detecting and/or forecasting seizures.

When the subjects clinical EEG monitoring is completed data scientists will analyze the data to identify patterns.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Development of a Practical, Minimally Invasive Seizure Gauge
Actual Study Start Date :
Nov 19, 2018
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Sep 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Other: Monitoring Device

Subjects will be asked to wear up to 4 different noninvasive seizure detection devices including EpiTel EpiLog, Byte Flies Sensor Dots, Empatica E4, Biovotion Everion, GeneActiv

Device: EpiTel EpiLog
Plastic pad that is about the size of a house key, and will be adhered to your scalp with gel
Other Names:
  • Epilog
  • Device: Byte Flies Sensor Dots
    Plastic pads that will be adhered to your chest area
    Other Names:
  • Byteflies
  • Sensor Dots
  • Device: Empatica E4
    wearable seizure detection wristband
    Other Names:
  • E4 Wristband
  • Device: Biovotion Everion
    wearable seizure detection device armband that is attached to upper arm

    Device: GeneActiv
    wearable seizure detection watch

    Outcome Measures

    Primary Outcome Measures

    1. Assessment of Physiological Signals Measurable with Wearable Sensors [2-10 days approximately]

      We will collect physiological signals with the five wearable, noninvasive biosensors listed below in Mayo patients undergoing scalp-recorded video EEG and invasive stereotactic EEG/video monitoring as part of their clinical epilepsy evaluation. We will evaluate biosignals based on data quality and reliability, and subject comfort and ease of use.

    2. Pattern Analysis [2-10 days approximately]

      We will apply data mining and machine learning methods to search for patterns in the collected physiological signals and correlate these patterns with the timing of seizures identified by the patient's clinical video-EEG monitoring.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    7 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients with epilepsy- scalp EEG or invasive EEG monitoring for clinical care, or an implanted device capable of monitoring brain activity and identifying seizures (e.g. NeuroPace RNS, Medtronic PC+S, Medtronic RC+S)

    • Pediatric subjects 7 years of age or older.

    Exclusion Criteria:
    • Cognitive or psychiatric condition rendering patient unable to cooperate with data collection, or manage and recharge smart watch and tablet computer devices.

    • Presence of open or healing wounds near monitoring sites (infection risk).

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mayo Clinic Rochester Minnesota United States 55905

    Sponsors and Collaborators

    • Mayo Clinic

    Investigators

    • Principal Investigator: Benjamin (Ben) H. Brinkmann, Ph.D., Mayo Clinic

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Benjamin H. Brinkmann, Principal Investigator, Mayo Clinic
    ClinicalTrials.gov Identifier:
    NCT03745118
    Other Study ID Numbers:
    • 18-008357
    First Posted:
    Nov 19, 2018
    Last Update Posted:
    Jan 5, 2022
    Last Verified:
    Jan 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Benjamin H. Brinkmann, Principal Investigator, Mayo Clinic
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 5, 2022